Community Health Systems Inc
SWB:CG5

Watchlist Manager
Community Health Systems Inc Logo
Community Health Systems Inc
SWB:CG5
Watchlist
Price: 3.06 EUR
Market Cap: €1.4B

Community Health Systems Inc
Investor Relations

Community Health Systems, Inc. engages in the management and operations of hospitals. The company is headquartered in Franklin, Tennessee and currently employs 66,000 full-time employees. The firm provides healthcare services through the hospitals that it owns and operates and affiliated businesses in non-urban and selected urban markets throughout the United States. The Services provided through its hospitals and affiliated businesses include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. The company also provides additional outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics and via direct-to-consumer virtual health visits. The company owns approximately 83 hospitals, comprised of 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 19, 2026
AI Summary
Q4 2025

Performance: Fourth quarter results were in line with updated expectations, with sequential margin expansion and stable cost controls.

Revenue: Same-store net revenue grew 2.1% year-over-year, mainly due to higher acuity and a 2.4% increase in net revenue per adjusted admission.

Divestitures: Significant hospital and asset sales in 2025 and early 2026 reduced debt and are expected to further strengthen the balance sheet.

Leverage: Year-end 2025 leverage improved to 6.6x from 7.4x in 2024; further deleveraging planned with upcoming divestiture proceeds.

2026 Guidance: Net revenue expected between $11.6B and $12.0B, with adjusted EBITDA of $1.34B to $1.49B—both below 2025 due to asset sales.

Cost Controls: Labor and supply expenses were well managed, with supply expense down 110 bps YoY and contract labor flat.

ACA Headwinds: Anticipated $20M–$30M EBITDA headwind in 2026 from lower health insurance exchange enrollment, but overall impact expected to be limited.

AI & Technology: Continued investment in AI and new ERP systems to drive efficiencies, cost savings, and quality improvements.

Key Financials
Adjusted EBITDA
$395 million (Q4 2025)
Adjusted EBITDA Margin
12.7% (Q4 2025)
Leverage
6.6x (year-end 2025)
Net Debt
$10.1 billion (year-end 2025)
Cash Flows from Operations
$266 million (Q4 2025); $543 million (full-year 2025)
Adjusted Cash Flows from Operations (ex-tax on divestitures)
$712 million (2025)
Adjusted Free Cash Flow
$150 million (2025)
Medical Specialist Fees
$169 million (Q4 2025)
Supply Expense
14.4% of net revenue (Q4 2025)
Earnings Call Recording
Other Earnings Calls

Management

Mr. Tim L. Hingtgen
CEO & Director
No Bio Available
Mr. Kevin J. Hammons CPA
President & CFO
No Bio Available
Mr. Kevin A. Stockton
Executive Vice President of Operations & Development
No Bio Available
Dr. Lynn T. Simon M.D., MBA
President of Healthcare Innovation & Chief Medical Officer
No Bio Available
Mr. Chad A. Campbell
President of Region 4 Operations
No Bio Available
Mr. Jason K. Johnson
Senior VP & Chief Accounting Officer
No Bio Available
Shelly Schussele
Senior Director of Investor Relations
No Bio Available
Mr. Justin D. Pitt
Executive VP, General Counsel & Assistant Secretary
No Bio Available
Ms. Beth Witte
Senior VP and Chief Compliance & Privacy Officer
No Bio Available
Ms. Tomi J. Galin
Executive Vice President of Corporate Communications, Marketing & Public Affairs
No Bio Available

Contacts

Address
TENNESSEE
Franklin
4000 Meridian Blvd
Contacts
+16154657000.0
www.chs.net
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett